357 Results (Page 14 of 15)
Indonesia Markets Research Reports
Indonesia Conjunctivitis Therapeutics Market Analysis
The Indonesia Conjunctivitis Therapeutics Market was valued at $25 Mn in 2022 and is predicted to grow at a CAGR of 5.4% from 2023 to 2030, to $37 Mn by 2030. The primary factors propelling this industry forward include the increasing prevalence of conjunctivitis, technological advancements, increasing government focus on preventative care, and others. The industry is primarily dominated by players such as Allergan, Bausch & Lomb, Alcon, Roche, Novartis, Santen, and Johnson & Johnson among others.
Indonesia Head and Neck Cancer Therapeutics Market Analysis
The Indonesia Head and Neck Cancer Therapeutics Market was valued at $44.65 Mn in 2023 and is predicted to grow at a CAGR of 10.70% from 2023 to 2030, to $90.96 Mn by 2030. The key drivers of this industry include the growing aging population, advancement in treatment, and government initiatives. The industry is primarily dominated by players such as Bristol Myers Squibb, Merck, Roche, and Pfizer among others.
Indonesia PET Scan Market Analysis
The Indonesia PET Scan Market was valued at $11.6 Mn in 2023 and is predicted to grow at a CAGR of 5.4% from 2023 to 2030, to $16.8 Mn by 2030. The key drivers of the market include expanding applications in medical field, rising advantages over other imaging techniques, and technological advancements. The prominent players of the Indonesia PET Scan Market are GE Healthcare, Siemens Healthineers, Toshiba, Schiller, and Hitachi, among others.
Indonesia Genomic Diagnostics Market Analysis
Indonesia Genomic Diagnostics Market was valued at $195.90 Mn in 2023 and is predicted to grow at a CAGR of 16.5% from 2023 to 2030, to $570.58 Mn by 2030. The key drivers of this industry include prevalence, technological advancements, and government initiatives. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
Indonesia Compression Therapy Market Analysis
Indonesia's Compression Therapy Market was valued at $23 Mn in 2022 and is estimated to reach $35 Mn in 2030, exhibiting a CAGR of 5.6% during the forecast period. The increasing occurrence of venous disorders such as leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a major factor contributing to the expansion of the compression therapy market. Major participants in this sector include companies like Medtronic plc, Sigvaris, Bauerfeind, Juzo, McKesson Corporation, Cardinal Health, BSN Medical, Hartmann, Lohmann & Rauscher, and Molnlycke Health Care.
Indonesia Bio-implant Market Analysis
The Indonesia Bio-implant Market was valued at $390 Mn in 2023 and is predicted to grow at a CAGR of 5.9% from 2023 to 2030, to $582.6 Mn by 2030. The Indonesia Bio-implant Market is growing due to like Growing Disposable Income, Increasing Aging Population, and Government Initiatives. The market is primarily dominated by players such as 3dindonesia, Boogie Medical Indonesia, Cipta Medika Indonesia, Zimmer Biomet, Stryker Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
Indonesia Mouth Ulcer Therapeutics Market Analysis
The Indonesia Mouth Ulcer Therapeutics Market was valued at $9.1 Mn in 2023 and is projected to grow at a CAGR of 3.9% from 2023 to 2023, to $11.9 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Kalbe Farma, AstraZeneca, Pfizer, Bayer, GSK among others.
Indonesia Exosome Research Market Analysis
The Indonesia Exosome Research Market was valued at $1.0 Mn in 2023 and is projected to grow at a CAGR of 16% from 2023 to 2023, to $2.9 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, increasing advanced applications of exosomes. The industry is primarily dominated by players such as Stem Cell and Cancer Institute, Prodia Group, Kalbe Farma, PT Bio Farma, Dexa Medica among others.
Indonesia Bariatric Surgery Devices Market Analysis
The Indonesia Bariatric Surgery Devices Market was valued at $16 Mn in 2023 and is projected to grow at a CAGR of 5.2% from 2023 to 2023, to $22.8 Mn by 2030. The market for bariatric surgical devices is being driven primarily by increased adult obesity rates, which are a result of changing lifestyles and consuming excessive amounts of calories. Over the course of the projection period, it is also expected that the demand for bariatric operations will increase as a result of growing public awareness of the harmful food and beverage options available in the market and how they affect body mass index (BMI), which will fuel the expansion of the bariatric surgery devices market. The prominent players in the market are Medtronic, B. Braun, Asenus Surgical, Johnson & Johnson, Cousin Surgery among others.
Indonesia CT Scan Market Analysis
Indonesia CT Scan Market was valued at $27.66Mn in 2023 and is predicted to grow at a CAGR of 7.87% from 2023 to 2030, to $47.01Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, increasing healthcare expenditure, and growing population and hospital development. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
Indonesia Cough Hypersensitivity Syndrome Therapeutics Market Analysis
The Indonesia Cough Hypersensitivity Syndrome Therapeutics Market was valued at $49 Mn in 2022 and is predicted to grow at a CAGR of 5.9% from 2023 to 2030, to $77 Mn by 2030. The primary factors propelling this sector comprise the rising prevalence of Cough Hypersensitivity Syndrome, the development of advanced therapeutics, and improving healthcare access. The industry is primarily dominated by players such as Johnson & Johnson, GSK, Sanofi, Novartis, AstraZeneca, Pfizer, and Boehringer Ingelheim among others.
Indonesia Lipid Disorder Therapeutics Market Analysis
Indonesia Lipid Disorder Therapeutics Market was valued at $369.7 Mn in 2023 and is predicted to grow at a CAGR of 10.83% from 2023 to 2030, to $759.3 Mn by 2030. Indonesia Lipid Disorder Therapeutics Market is growing due to Shifting Demographics, Growing Awareness, and Increasing Healthcare Expenditure. The industry is primarily dominated by players such as Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
Indonesia Mental Health Apps Market Analysis
The Indonesia Mental Health Apps Market was valued at $37.2 Mn in 2023 and is predicted to grow at a CAGR of 15.2% from 2023 to 2030, to $100.16 Mn by 2030. The key drivers of this industry include increasing smartphone penetration, rising incidences, and a shortage of health workers. The industry is primarily dominated by players such as HeadSpace, Calm, Happify, and Teduh among others.
Indonesia Constipation Therapeutics Market Analysis
Indonesia Constipation Therapeutics Market was valued at $109 Mn in 2022 and is estimated to reach $181 Mn in 2030, exhibiting a CAGR of 6.5% during the forecast period. The constipation therapeutics market is experiencing growth driven by the rising prevalence of constipation worldwide, attributed to factors like aging, sedentary lifestyles, and unhealthy dietary habits, with the expanding elderly population, more prone to chronic conditions, further contributing to this market expansion. Notable participants in this industry include Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novartis, Pfizer, Roche, and Sanofi.
Indonesia Herbal Supplements Market Report
The Indonesia Herbal Supplements Market was valued at $31.56 Mn in 2023 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $48.08 Mn by 2030. The key drivers of this industry include a younger population, cultural acceptance, and rising awareness. The industry is primarily dominated by players such as Himalaya Wellness, Herbalife Nutrition, Sido Muncul, and Deltomed Laboratories among others.
Indonesia Brain Cancer Therapeutics Market
Indonesia Brain Cancer Therapeutics Market valued at $14 Mn in 2022, projected to reach $31 Mn by 2030 with a 10.6% CAGR. The anticipated increase in cases of brain cancer, particularly glioblastoma multiforme, is expected to markedly boost the need for brain cancer therapeutics, shaping the overall market landscape significantly. The top leading pharmaceutical companies currently operating in the market are Roche, Novartis, Pfizer, Merck, AstraZeneca, Bristol Myers Squibb, Eli Lilly, Sanofi, Johnson & Johnson and Takeda.
Indonesia Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Indonesia Clinical Nutrition for Chronic Kidney Diseases Market was valued at $9.40 Mn in 2023 and is predicted to grow at a CAGR of 6.03% from 2023 to 2030, to $14.20 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, technological advancements, and increasing healthcare expenditure. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Indonesia Adult Malignant Glioma Therapeutics Market Analysis
The Indonesia Adult Glioma Therapeutics Market is valued at around $13 Mn in 2022 and is projected to reach $26 Mn by 2030, exhibiting a CAGR of 8.9% during the forecast period. The UHC program of the Indonesian government, together with the nation's expanding economic might and a rise in domestic investment and research projects, is greatly boosting the manufacture of generic drugs domestically and encouraging the development of diagnostic and therapeutic technologies. Key players in the Indonesia Adult Malignant Glioma Therapeutics Market include companies like Roche, Novartis, Merck & Co., Pfizer, Bristol-Myers Squibb, Kalbe Farma, Stryker, Elekta, Siemens, etc among others
Indonesia Blood Disorder Therapeutics Market
Indonesia Blood Disorder Therapeutics Market valued at $80 Mn in 2022, projected to reach $143 Mn by 2030 with a 7.5% CAGR. The market growth is fuelled due to certain factors such as the increasing incidence of blood disorders in Indonesia, driven by improved diagnostics and accessibility, heightened awareness, identification of genetic and environmental risk factors, and rising investments in healthcare. The Indonesia Blood Disorder Therapeutics Market encompasses various players across different segments, including Roche, Novartis, Pfizer, Bayer, BioMarin Pharmaceutical, Takeda, Kalbe Farma, Dexa Medica, Combiphar, Kimia Farma, etc, among various others.
Indonesia Dental Endodontics Market Analysis
Indonesia Dental Endodontics Market was valued at $10.50 Mn in 2023 and is predicted to grow at a CAGR of 4.3% from 2023 to 2030, to $14.10 Mn by 2030. The key drivers of this industry include a rising awareness of oral health, a growing geriatric population, and an expansion of dental tourism. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
Indonesia Clinical Nutrition Market Analysis
The Indonesia Clinical Nutrition Market was valued at $184 Mn in 2023 and is projected to grow at a CAGR of 5.34% from 2023 to 2023, to $264.9 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Nature’s Sunshine Products, Darya-Varia Laboratoria Tbk, Bio Farma and Citra Nusa Insan Cemerlang.
Indonesia Breast Pump Market Report
The Indonesia Breast Pump Market was valued at $17.6 Mn in 2023 and is predicted to grow at a CAGR of 8.6% from 2023 to 2030, to $31.4 Mn by 2030. The key drivers of the market include urbanization, increasing presence of females in the workforce, and growing consumer awareness. The prominent players in the Indonesia Breast Pump Market are Cimilre, Horigen, Pigeon, Asia Connection, Philips Avent, Advin Healthcare, and IndoSurgicals, among others.
Indonesia Congestive Heart Failure Therapeutics Market Analysis
The Indonesia Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $62 Mn in 2022 to $97 Mn by 2030, with a CAGR of 5.8% during the forecast period of 2022-2030. The growth of the Indonesia Congestive Heart Failure Therapeutics Market is driven by the increasing prevalence of cardiovascular conditions among an aging population, government initiatives enhancing accessibility and affordability, and the potential for healthcare infrastructure improvements, particularly in rural areas. The Indonesia Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including Novartis, Sanofi, AstraZeneca, Bayer, Eli Lilly, Merck, Kalbe Pharma, Kimia Pharma, Pharos, Indopharma, etc., among various others.
Indonesia Digital Biomarkers Market Analysis
Indonesia Digital Biomarkers Market was valued at $17.40 Mn in 2023 and is predicted to grow at a CAGR of 22.3% from 2023 to 2030, to $71.21 Mn by 2030. The key drivers of this industry include the growing prevalence of chronic diseases, government initiatives, and a growing focus on preventative care. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Indonesia Medication Access Programs Market Analysis
The Indonesia Medication Access Programs Market was valued at $32.9 Mn in 2023 and is predicted to grow at a CAGR of 14.6% from 2023 to 2030, to $85.5 Mn by 2030. The key drivers of this industry include healthcare infrastructure, rising healthcare awareness, and a growing disease burden. The industry is primarily dominated by players such as Takeda Pharmaceuticals, Pfizer, Novartis, and Merck among others
